Literature DB >> 32437967

Screening migrants from tuberculosis high-endemic countries for latent tuberculosis in Oman: A cross sectional cohort analysis.

Fatma Alyaquobi1, Ali A AlMaqbali2, Amina Al-Jardani3, Nduku Ndunda4, Bader Al Rawahi1, Badr Alabri5, Ahmed Mohammed AlSadi2, Jamal A AlBaloshi2, Fatma S Al-Baloshi2, Naima A Al-Essai2, Saleh A Al-Azri3, Samiya M Al-Zadjali3, Laila M Al-Balushi3, Eskild Petersen6, Seif Al-Abri7.   

Abstract

To fulfil the World Health Organization (WHO) End TB strategy, screening for tuberculosis (TB) in immigrants is an important component of the strategy to reduce the TB burden in low-incidence countries. Oman has an annual TB incidence rate of 5.7 per 100000 and transmission from migrants with activated latent TB infection (LTBI) to nationals is a concern. The aim of this study was to determine the proportion of migrants to the Sultanate of Oman with LTBI. The study used an interferon-gamma release assay (IGRA) to assess previous exposure to TB, defining LTBI and a positive IGRA with a normal chest X-ray. 1049 subjects were surveyed. Six participants were excluded from the analysis as they had been recently vaccinated and 1 had an indeterminate result, thus 1042 subjects were included. The overall IGRA-positive rate was 22.4% (234/1042), 30.9% and 21.2% of African and Asian migrants, respectively, were IGRA-positive. Fifty-eight of the participants had a strong IGRA reactivity defined as more than 4 IU/ml. The study shows the proportion of migrants from Asia and Africa with LTBI and 24.7% (58/234) of IGRA-positive migrants had an IGRA of >4 IU/ml, defining a subpopulation with a high risk of developing active TB in the first two years of arrival to the country.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Communicable disease; End TB Strategy; Immigrants; Interferon-gamma release test; Oman

Year:  2020        PMID: 32437967     DOI: 10.1016/j.tmaid.2020.101734

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  2 in total

1.  Oman, a Pathfinder Towards Tuberculosis Elimination: The journey begins.

Authors:  Fatma Al Yaquobi; Seif Al-Abri
Journal:  Sultan Qaboos Univ Med J       Date:  2022-02-28

2.  Importance of Tuberculosis Screening of Resident Visa Applicants in Low TB Incidence Settings: Experience from Oman.

Authors:  Jeffrey Singh; Seif Al-Abri; Eskild Petersen; Fatma Al Yaqoubi; Khoula Al Rahbi; Lamya Al Balushi; Fatma Al Fahdi; Asma Al Balushi; Farah Mahmmoud M Jawad; Padmamohan J Kurup
Journal:  J Epidemiol Glob Health       Date:  2022-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.